23Indexed trials
mesh condition
Breast Neoplasms
Intelligence
Breast Neoplasms intelligence: 23 indexed trials, 6 recruiting studies, 22 sponsors across 41 countries.
6Recruiting
22Sponsors
41Countries
Leading sponsors
Indiana University20 recruiting
Alliance Equiphoria10 recruiting
Chinese PLA General Hospital11 recruiting
Duke University10 recruiting
Emory University10 recruiting
GlaxoSmithKline10 recruiting
Hacettepe University10 recruiting
Merck Sharp & Dohme LLC11 recruiting
NeuroVita Clinic10 recruiting
New Mexico Cancer Research Alliance11 recruiting
South Sound Care Foundation10 recruiting
Universidad de Granada10 recruiting
Geographic activity
United States10trials
Turkey (Türkiye)4trials
France3trials
China2trials
Belgium2trials
Spain2trials
Germany1trials
Chile1trials
Finland1trials
Canada1trials
Czechia1trials
Colombia1trials
Leading interventions
psychosocial assessment and care2trials
Pain Neuroscience Education2trials
fatigue assessment and management2trials
quality-of-life assessment2trials
Usual care2trials
Cognitive restructuring1trials
Carboplatin1trials
Behavioural Graded Activity1trials
DECAD decision aid1trials
Cyclophosphamide1trials
Dendritic vaccine, allogeneic hematopoietic stem cells, cytotoxic lymphocytes1trials
Capecitabine1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.